Evidence map›Paper›PMID 39547646›Full record

ArticlePractical radiation oncology

Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity Modulated Radiation Therapy for Intact Cervical Cancer: An Update.

Emma C Fields, Walter R Bosch, Kevin V Albuquerque, Rohini Bhatia, Junzo Chino, Brandon Dyer, Beth Erickson, Denise Fabian, David Gaffney, Scott Glaser and 23 more

Abstract read
In one paragraph

Article in Practical radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Emma C FieldsDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: emma.fields@vcuhealth.org.
Walter R BoschDepartment of Radiation Oncology, Washington University, St. Louis, Missouri.
Kevin V AlbuquerqueDepartment of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas.
Rohini BhatiaDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins, Baltimore, Maryland.
Junzo ChinoDepartment of Radiation Oncology, Duke University, Durham, North Carolina.
Brandon DyerDepartment of Radiation Oncology, University of Washington, Seattle, Washington.
Beth EricksonDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Denise FabianDepartment of Radiation Oncology, University of Kentucky, Lexington, Kentucky.
David GaffneyDepartment of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Scott GlaserDepartment of Radiation Oncology, City of Hope, Duarte, California.
Kathy HanDepartment of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Lara HathoutDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
I-Chow HsuDepartment of Radiation Oncology, University of California San Francisco, San Francisco, California.
Naresh JegadeeshDepartment of Radiation Oncology, Cook County Health, Chicago, Illinois.
Jenna KahnDepartment of Radiation Oncology, Kaiser Permanente NW Region, Portland, Oregon.
Elizabeth KiddDepartment of Radiation Oncology, Stanford University, Palo Alto, California.
Ann KloppDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Eric LeungDepartment of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Lilie LinDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Michelle LudwigDepartment of Radiation Oncology, Baylor College of Medicine, Houston, Texas.
Tianjun MaDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.
Loren MellDepartment of Radiation Oncology, University of California San Diego, San Diego, California.
Jyoti MayadevDepartment of Radiation Oncology, University of California San Diego, San Diego, California.
Ivy PetersenDepartment of Radiation Oncology, Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota.
Lorraine PortelanceDepartment of Radiation Oncology, University of Miami Health System, Miami, Florida.
Dominique RashDepartment of Radiation Oncology, University of California San Diego, San Diego, California.
Neil TaunkDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Akila ViswanathanDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins, Baltimore, Maryland.
Aaron WolfsonDepartment of Radiation Oncology, University of Miami Health System, Miami, Florida.
Catheryn YasharDepartment of Radiation Oncology, University of California San Diego, San Diego, California.
Anamaria YeungDepartment of Radiation Oncology, University of Florida, Gainesville, Florida.
Emi YoshidaDepartment of Radiation Oncology, University of California San Francisco, San Francisco, California.
Christine M FisherDepartment of Radiation Oncology, University of Colorado, Aurora, Colorado.

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
UT Southwestern NCI National Clinical Trials Network (NCTN) LAPS - Supplemental Funds YR4UG1CA233302 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI David Eric Gerber · 2019 to 2026
$6.4M
NCI NIH HHS U10 CA180868NCI NIH HHS U24 CA180803NCI NIH HHS UG1 CA233302
6 · The paper itself

Abstract

purposeAccurate target delineation is essential when using intensity modulated radiation therapy for intact cervical cancer. In 2011, the Radiation Therapy Oncology Group published a consensus guideline using magnetic resonance imaging (MRI). The current project expands on the previous atlas by including computed tomography (CT)-based contours, contours with MRI and positron emission tomography (PET) registrations, the addition of common and complex scenarios, and incorporating information on simulation and treatment planning techniques. METHODS AND MATERIALS: Twenty-eight experts in gynecologic radiation oncology contoured 3 cases, first on a noncontrast CT simulation scan and then with registered diagnostic scans. The cases included (1) International Federation of Gynecology and Obstetrics (FIGO) IIIC1 with a bulky tumor and vaginal metastasis, (2) FIGO IIB with calcified uterine fibromas, and (3) FIGO IIIC2 with large lymph nodes. The contours on all 6 data sets (3 CT simulations without diagnostic images and 3 with registered images) were analyzed for consistency of delineation using an expectation-maximization algorithm for simultaneous truth and performance level estimation with kappa statistics as a measure of agreement. The contours were reviewed, discussed, and edited in a group meeting prior to finalizing.

resultsContours showed considerable agreement among experts in each of the cases, with kappa statistics from 0.67 to 0.72. For each case, diagnostic PET ± MRI was associated with an increase in volume. The largest increase was the clinical target volume (CTV) primary for case 2, with a 20% increase in volume and a 54% increase in simultaneous truth and performance level estimation volume, which may be due to variance in registration priorities. For the third case, 92.9% increased their CTVs based on the addition of the diagnostic PET scan. The main areas of variance were in determining the superior extent of CTV coverage, coverage of the mesorectum, and simulation and planning protocols.

conclusionsThis study shows the value and the challenges of using coregistered diagnostic imaging, with an average increase in volumes when incorporating MRI and PET.

Indexed as

Radiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedUterine Cervical NeoplasmsConsensusFemaleHumansMagnetic Resonance ImagingPositron-Emission TomographyTomography, X-Ray Computed

Identifiers

PMID39547646
PMCPMC11954667

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.